COMMENTARYThe downside of isoniazid chemoprophylaxis
References (12)
- et al.
Cost-effectiveness of chemotherapy for pulmonary tuberculosis in sub-Saharan African countries
Lancet
(1991) - et al.
Effects of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection
Lancet
(1993) - et al.
The epidemiology of tuberculosis in San Francisco: a population based study using conventional and molecular epidemiologic methods
N Engl J Med
(1994) - et al.
Use of PCR based DNA techniques in evaluating cluster outbreaks of tuberculosis (TB)
Clin Invest Med
(1993) Tuberculosis guide for high prevalence countries
(1993)- et al.
A cost effectiveness analysis of the routine use of isoniazid prophylaxis in patients with a positive Mantoux skin test
Am Rev Respir Dis
(1990)
There are more references available in the full text version of this article.
Cited by (6)
Tuberculosis and other mycobacterial infections
2010, Antibiotic and Chemotherapy: Expert ConsultCommunity infection ratio as indicator for tuberculosis control
1995, The LancetIsoniazid
2017, Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh EditionTuberculosis infection and disease among persons seeking social services in New York City
1997, International Journal of Tuberculosis and Lung DiseaseTuberculosis into the next century
1996, Journal of Medical Microbiology
Copyright © 1995 Published by Elsevier Ltd.